Investors Capital Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Investors Capital Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,196	Closed	-$587K	–	709
2015 Q4	$587K	Sell	5,196 -600	-10%	-$64.6K	0.11%	247
2015 Q3	$587K	Buy	5,796 +21	+0.4%	+$2.5K	0.12%	247
2015 Q2	$716K	Buy	5,775 +371	+7%	+$44.8K	0.13%	223
2015 Q1	$638K	Sell	5,404 -150	-3%	-$17K	0.12%	244
2014 Q4	$566K	Buy	5,554 +200	+4%	+$19.5K	0.11%	268
2014 Q3	$491K	Buy	5,354 +15	+0.3%	+$1.3K	0.1%	305
2014 Q2	$439K	Buy	+5,339	New	+$408K	0.07%	375

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Investors Capital Advisory Services's FBT Position: Q1 2016 in Review

Investors Capital Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2016, closing a stake of 5,196 shares — an estimated $587K sold.

Investors Capital Advisory Services first reported a position in FBT in Q2 2014 and held it in 7 quarters. The position peaked at $716K in Q2 2015. 107 funds tracked by Wall St. Rank hold FBT as of Q1 2016.

Investors Capital Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2016 after selling out during the quarter.
Investors Capital Advisory Services sold 5,196 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2016, an estimated $587K.
Investors Capital Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and held it in 7 quarters.
Investors Capital Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $716K in Q2 2015.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2016.

Based on Investors Capital Advisory Services's 13F filing for Q1 2016, filed 9 May 2016.